Current Opinion in Plant Biology, ISSN 1369-5266, 12/2015, Volume 28, Issue C, pp. 68 - 75
In plants and fungi, energetics at the plasma membrane is provided by a large protonmotive force (PMF) generated by the family of P-type ATPases specialized...
FERONIA | ARABIDOPSIS-THALIANA | PROTEIN-KINASE | HYPOCOTYL ELONGATION | SMALL AUXIN | GROWTH | BIOCHEMICAL-CHARACTERIZATION | GUARD-CELLS | BLUE-LIGHT | PROMOTE CELL EXPANSION | PLANT SCIENCES | Cell membranes | Plant physiology | Phosphotransferases | Adenosine triphosphatase | Proteins | Arabidopsis thaliana | Endocrine disruptors | Phosphatases | Abscisic acid | Cellular signal transduction | Mass spectrometry
FERONIA | ARABIDOPSIS-THALIANA | PROTEIN-KINASE | HYPOCOTYL ELONGATION | SMALL AUXIN | GROWTH | BIOCHEMICAL-CHARACTERIZATION | GUARD-CELLS | BLUE-LIGHT | PROMOTE CELL EXPANSION | PLANT SCIENCES | Cell membranes | Plant physiology | Phosphotransferases | Adenosine triphosphatase | Proteins | Arabidopsis thaliana | Endocrine disruptors | Phosphatases | Abscisic acid | Cellular signal transduction | Mass spectrometry
Journal Article
Plant Physiology, ISSN 0032-0889, 01/2018, Volume 176, Issue 1, pp. 364 - 377
A P-type H+-ATPase is the primary transporter that converts ATP to electrochemical energy at the plasma membrane of higher plants. Its product, the...
BINDING CASSETTE TRANSPORTER | ARABIDOPSIS-THALIANA | CELL EXPANSION | P-TYPE ATPASE | IMAGE-ANALYSIS | FLUORESCENT PROTEIN | EXTRACELLULAR PH | PROTON PUMP | FUNCTIONAL GENOMICS | LIVING CELLS | PLANT SCIENCES | Phosphotransferases - metabolism | Arabidopsis - enzymology | Plant Roots - metabolism | Fluorescent Dyes - metabolism | Organ Specificity | Recombinant Fusion Proteins - metabolism | Seedlings - growth & development | Arabidopsis - genetics | Arabidopsis Proteins - metabolism | Proton-Translocating ATPases - metabolism | Arabidopsis - radiation effects | Cell Membrane - enzymology | Intracellular Space - metabolism | Light | Environment | Seedlings - radiation effects | Plant Roots - growth & development | Plant Roots - radiation effects | Cell Membrane - radiation effects | Hydrogen-Ion Concentration
BINDING CASSETTE TRANSPORTER | ARABIDOPSIS-THALIANA | CELL EXPANSION | P-TYPE ATPASE | IMAGE-ANALYSIS | FLUORESCENT PROTEIN | EXTRACELLULAR PH | PROTON PUMP | FUNCTIONAL GENOMICS | LIVING CELLS | PLANT SCIENCES | Phosphotransferases - metabolism | Arabidopsis - enzymology | Plant Roots - metabolism | Fluorescent Dyes - metabolism | Organ Specificity | Recombinant Fusion Proteins - metabolism | Seedlings - growth & development | Arabidopsis - genetics | Arabidopsis Proteins - metabolism | Proton-Translocating ATPases - metabolism | Arabidopsis - radiation effects | Cell Membrane - enzymology | Intracellular Space - metabolism | Light | Environment | Seedlings - radiation effects | Plant Roots - growth & development | Plant Roots - radiation effects | Cell Membrane - radiation effects | Hydrogen-Ion Concentration
Journal Article
Journal of Catalysis, ISSN 0021-9517, 2011, Volume 278, Issue 1, pp. 8 - 15
In propene epoxidation with O and H , Au clusters (1.0–2.0 nm) on exterior surfaces of TS-1 treated with NaOH were more active than tiny Au clusters (<0.55 nm)...
O 2/H 2 mixture | 129Xe NMR | Alkaline-treated TS-1 | Propene epoxidation | Gold clusters | VAPOR-PHASE EPOXIDATION | OXIDATION | Xe-129 NMR | PROPYLENE EPOXIDATION | OXIDE | TS-1 | O-2/H-2 mixture | CHEMISTRY, PHYSICAL | XE-129 NMR-SPECTROSCOPY | ENGINEERING, CHEMICAL | GAS-PHASE | ZEOLITES | CATALYSTS
O 2/H 2 mixture | 129Xe NMR | Alkaline-treated TS-1 | Propene epoxidation | Gold clusters | VAPOR-PHASE EPOXIDATION | OXIDATION | Xe-129 NMR | PROPYLENE EPOXIDATION | OXIDE | TS-1 | O-2/H-2 mixture | CHEMISTRY, PHYSICAL | XE-129 NMR-SPECTROSCOPY | ENGINEERING, CHEMICAL | GAS-PHASE | ZEOLITES | CATALYSTS
Journal Article
Plant Physiology, ISSN 0032-0889, 1/2018, Volume 176, Issue 1, pp. 364 - 377
Cellular dynamics and localization of plasma membrane H + - ATPase is determined by cell type, light condition, and a receptor kinase, FERONIA, which regulates...
s - Focus Issue
s - Focus Issue
Journal Article
Plant Physiology (Bethesda), ISSN 0032-0889, 10/2017, Volume 176, Issue 1
Not provided.
Plant Sciences
Plant Sciences
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1319 - 1330
In patients with stable cardiovascular disease, those receiving rivaroxaban plus aspirin had fewer major cardiovascular events but more major bleeding events...
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Life Sciences | Human health and pathology
TRIAL | MEDICINE, GENERAL & INTERNAL | RISK | ORAL RIVAROXABAN | CLOPIDOGREL | SECONDARY PREVENTION | Atherosclerosis - drug therapy | Double-Blind Method | Cardiovascular Diseases - drug therapy | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Atherosclerosis - complications | Male | Secondary Prevention - methods | Factor Xa Inhibitors - therapeutic use | Rivaroxaban - adverse effects | Aspirin - adverse effects | Factor Xa Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Aged | Aspirin - therapeutic use | Hemorrhage - chemically induced | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Rivaroxaban - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Rivaroxaban | Aspirin | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Research | Cardiovascular diseases | Drug therapy | Observations | Methods | Myocardial infarction | Cerebral infarction | Medical research | Cardiovascular disease | Bleeding | Studies | Disease prevention | Arteriosclerosis | Coronary vessels | Atherosclerosis | Drug dosages | Life Sciences | Human health and pathology
Journal Article